Skip to main content

Table 1 Baseline characteristics and conventional atherothrombotic risk factors of the study groups

From: Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects

 

Overweight subjects

Normal weight subjects with CHD

Controls

No. of subjects

275

337

103

BMI, kg/m2

29.67 ± 2.56***

23.85 ± 2.01

23.92 ± 1.88

Age, yr

61.36 ± 10.39

62.01 ± 11.18

61.95 ± 14.79

Male gender, n (%)

211 (76.7%)

251 (74.4%)

74 (71.8%)

Diabetes mellitus, n (%)

107 (38.9%)***

168 (49.8%)***

6 (5.8%)

Hypertension, n (%)

173 (62.9)**

184 (54.6%)

49 (47.5%)

Smokers, n (%)

32 (11.6%)

68 (20.2%)**

7 (6.8%)

Hypercholesterolemia, n (%)

121 (44%)**

115 (34.1%)

30 (29.1%)

Lp(a) (mg/dl)

16.2 (4–43)

19.6 (5.2–49)

14.9 (4.3–45.3)

  1. BMI, body mass index; CHD, coronary heart disease; Lp(a), lipoprotein(a). Lp(a) levels are expressed as medians (interquartile range within brackets). **P < 0.01 ***P < 0.001, versus controls.